Key Highlights
- Heidi Chen named Chief Legal Officer at GeneDx, effective November 25, 2024.
- Brings over 30 years of legal and compliance expertise to the role.
- Previously General Counsel at Zoetis, instrumental in its growth post-Pfizer spinoff.
- Will oversee legal, compliance, policy, and corporate governance functions.
- Aims to drive innovation and transformative patient care at GeneDx.
Source: Business Wire
Notable Quotes
- “With a massive transformation behind us and a clear runway for growth ahead, Heidi brings the expertise and leadership needed to guide GeneDx into this next chapter, particularly given the changing landscape in healthcare.” — Katherine Stueland, CEO and President at GeneDx
- “I’m honored to have the opportunity to help accelerate GeneDx’s growth and continue transforming patient care. I look forward to collaborating with the talented team at GeneDx to push boundaries, drive disruptive change, and pioneer innovations that deliver meaningful improvements in health outcomes.” — Heidi Chen, Chief Legal Officer at GeneDx
SoHC's Take
The appointment of Heidi Chen as Chief Legal Officer signifies GeneDx’s commitment to strengthening its leadership team as it navigates a new phase of growth. Chen’s robust background in corporate governance, regulatory compliance, and operational strategy uniquely positions her to tackle the complexities of the genomic healthcare industry. Her proven track record at Zoetis, where she built foundational legal structures and supported rapid business expansion, aligns with GeneDx’s mission to lead innovation in precision medicine. This strategic hire underscores the company’s focus on driving sustainable growth while pioneering advancements in patient care and healthcare transformation.
